Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1136)	5/11/1998 6:02:00 PM
From: Steve Harmon	Respond to of 2742

Sounds like Congress is in control of this company. Isn't it odd that CISTRON's price is LOWER with Bluestone on board than before they signed up....Stock support? I bet that if they had a strike price on the remainder of the 400,000 warrants at these levels our shares would be much higher than $1. A aggressive CEO would not have set up the Bluestone deal in such a fashion. 1)Make the strike price on the remaining warrants at higher levels. Don't leave it open ended as it has been for 7 months now. That would make Bluestone be a aggressive supporter of the stock. Or2)END THE BLUESTONE CONTRACT leaving them with just the original 400,000 shares at .25 cents.(This should have been the original set up anyway.) I have seen financial advisors give stocks much better stock support with far less stock options in the recent past.(Bluestone of course has given none).